Mortality in End-Stage Cirrhosis with Alcohol Withdrawal During Hospital Admission

Specific Mortality Data by Clinical Context

• One-year mortality is 49% following ascites and variceal bleeding, and 64% after hepatic encephalopathy episodes in patients with decompensated alcoholic cirrhosis 2
• The 5-year mortality rate for decompensated alcoholic cirrhosis is 70% with continued drinking and 40% with abstinence, according to the American Association for the Study of Liver Diseases 1

Severity-Specific Outcomes

• Patients with Child-Pugh C cirrhosis who continue drinking have 100% mortality at 3 years, versus 75% 3-year survival with complete abstinence, as recommended by the European Association for the Study of the Liver 3
• 80% of patients who continue drinking in the presence of ascites will die within 7 months, highlighting the importance of abstinence in patient management 4, 1

Critical Factors Amplifying Mortality Risk

• Active alcohol withdrawal increases infection risk to 22.5% versus 6% in non-active drinkers, even with antibiotic prophylaxis, according to the American College of Gastroenterology 5
• Patients with ACLF-3 (≥3 organ failures) have approximately 90% 90-day mortality when CLIF-C ACLF score exceeds 70, as reported by the European Association for the Study of the Liver 6

Alcohol-Specific Pathophysiology Worsening Outcomes

• Even moderate alcohol consumption (0.5 g/kg) acutely worsens portal hypertension within 15 minutes, deteriorating azygos blood flow and hepatic venous pressure gradient, as studied by the American Association for the Study of Liver Diseases 2, 7, 3
• Bacterial infection leads to approximately fourfold increase in mortality regardless of cirrhosis etiology, emphasizing the need for prompt infection control measures 7, 5

Prognostic Stratification for Clinical Decision-Making

• MELD score >20 predicts high 90-day mortality, while Maddrey Discriminant Function >32 predicts 40% 1-month mortality in severe alcoholic hepatitis, according to the American Association for the Study of Liver Diseases 8, 1
• Presence of systemic inflammatory response syndrome (SIRS) on admission increases risk of multiorgan failure syndrome with very high mortality, highlighting the importance of early recognition and intervention 8

Futility Thresholds

• Patients with NACSELD ACLF (≥2 organ failures) have only 3% 28-day survival, indicating a high risk of mortality 6
• CLIF-C ACLF score >70 at admission or Day 3 is associated with approximately 90% 90-day mortality, emphasizing the need for aggressive management strategies 6

Critical Clinical Pitfalls

• Poor nutritional status and sarcopenia affect up to 50% of patients with alcoholic liver disease, independently contributing to infection risk and mortality, as reported by the European Society for Clinical Nutrition and Metabolism 7, 5